Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer
- PMID: 17545691
- DOI: 10.1001/jama.297.21.2410
Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer
Comment on
-
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA. 2007 Jun 6;297(21):2360-72. doi: 10.1001/jama.297.21.2360. Epub 2007 Jun 3. JAMA. 2007. PMID: 17545690
Similar articles
-
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA. 2007 Jun 6;297(21):2360-72. doi: 10.1001/jama.297.21.2360. Epub 2007 Jun 3. JAMA. 2007. PMID: 17545690
-
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.Clin Cancer Res. 2005 Aug 1;11(15):5401-9. doi: 10.1158/1078-0432.CCR-05-0247. Clin Cancer Res. 2005. PMID: 16061854
-
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11. Gastroenterology. 2015. PMID: 26072394
-
[Preventive resection of hereditary diffuse gastric cancer].Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2417-20. Ned Tijdschr Geneeskd. 2006. PMID: 17131699 Review. Dutch.
-
[From gene to disease; E-cadherin and hereditary diffuse gastric cancer].Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2474-7. Ned Tijdschr Geneeskd. 2003. PMID: 14708213 Review. Dutch.
Cited by
-
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.BMC Med Genomics. 2016 Apr 11;9:19. doi: 10.1186/s12920-016-0178-5. BMC Med Genomics. 2016. PMID: 27067391 Free PMC article.
-
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.J Hematol Oncol. 2019 Apr 11;12(1):38. doi: 10.1186/s13045-019-0725-6. J Hematol Oncol. 2019. PMID: 30975222 Free PMC article. Review.
-
Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.Mol Cancer. 2009 Aug 12;8:63. doi: 10.1186/1476-4598-8-63. Mol Cancer. 2009. PMID: 19671196 Free PMC article.
-
CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.Mol Biol Rep. 2012 Aug;39(8):8107-13. doi: 10.1007/s11033-012-1658-0. Epub 2012 Apr 26. Mol Biol Rep. 2012. PMID: 22535324
-
Hereditary breast cancer: the era of new susceptibility genes.Biomed Res Int. 2013;2013:747318. doi: 10.1155/2013/747318. Epub 2013 Mar 21. Biomed Res Int. 2013. PMID: 23586058 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous